Report Detail
Global Drugs for Osteoarthritis Pain Market Growth (Status and Outlook) 2019-2024
- RnM3040601 |
- 28 February, 2019 |
- Global |
- 133 Pages |
- LPI(LP Information) |
- Other
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Rest of World (RoW). The North America held the largest share in the global market, its revenue of global market exceeds 38% in 2017. The next is Europe.
According to this study, over the next five years the Drugs for Osteoarthritis Pain market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 10400 million by 2024, from US$ 7440 million in 2019. In particular, this report presents the global revenue market share of key companies in Drugs for Osteoarthritis Pain business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Drugs for Osteoarthritis Pain market by product type, application, key companies and key regions.
This study considers the Drugs for Osteoarthritis Pain value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Oral
Injection
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Medical Care
Personal Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Drugs for Osteoarthritis Pain market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Drugs for Osteoarthritis Pain market by identifying its various subsegments.
Focuses on the key global Drugs for Osteoarthritis Pain players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drugs for Osteoarthritis Pain with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Drugs for Osteoarthritis Pain submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Drugs for Osteoarthritis Pain Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Drugs for Osteoarthritis Pain Market Size 2014-2024
- 2.1.2 Drugs for Osteoarthritis Pain Market Size CAGR by Region
- 2.2 Drugs for Osteoarthritis Pain Segment by Type
- 2.2.1 Oral
- 2.2.2 Injection
- 2.2.3 External
- 2.3 Drugs for Osteoarthritis Pain Market Size by Type
- 2.3.1 Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (2014-2019)
- 2.4 Drugs for Osteoarthritis Pain Segment by Application
- 2.4.1 Medical Care
- 2.4.2 Personal Care
- 2.5 Drugs for Osteoarthritis Pain Market Size by Application
- 2.5.1 Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (2014-2019)
3 Global Drugs for Osteoarthritis Pain by Players
- 3.1 Global Drugs for Osteoarthritis Pain Market Size Market Share by Players
- 3.1.1 Global Drugs for Osteoarthritis Pain Market Size by Players (2017-2019)
- 3.1.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Players (2017-2019)
- 3.2 Global Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Drugs for Osteoarthritis Pain by Regions
- 4.1 Drugs for Osteoarthritis Pain Market Size by Regions
- 4.2 Americas Drugs for Osteoarthritis Pain Market Size Growth
- 4.3 APAC Drugs for Osteoarthritis Pain Market Size Growth
- 4.4 Europe Drugs for Osteoarthritis Pain Market Size Growth
- 4.5 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth
5 Americas
- 5.1 Americas Drugs for Osteoarthritis Pain Market Size by Countries
- 5.2 Americas Drugs for Osteoarthritis Pain Market Size by Type
- 5.3 Americas Drugs for Osteoarthritis Pain Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Drugs for Osteoarthritis Pain Market Size by Countries
- 6.2 APAC Drugs for Osteoarthritis Pain Market Size by Type
- 6.3 APAC Drugs for Osteoarthritis Pain Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Drugs for Osteoarthritis Pain by Countries
- 7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type
- 7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Drugs for Osteoarthritis Pain by Countries
- 8.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type
- 8.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Drugs for Osteoarthritis Pain Market Forecast
- 10.1 Global Drugs for Osteoarthritis Pain Market Size Forecast (2019-2024)
- 10.2 Global Drugs for Osteoarthritis Pain Forecast by Regions
- 10.2.1 Global Drugs for Osteoarthritis Pain Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Drugs for Osteoarthritis Pain Forecast by Type
- 10.8 Global Drugs for Osteoarthritis Pain Forecast by Application
11 Key Players Analysis
- 11.1 Pfizer
- 11.1.1 Company Details
- 11.1.2 Drugs for Osteoarthritis Pain Product Offered
- 11.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Pfizer News
- 11.2 Johnson & Johnson
- 11.2.1 Company Details
- 11.2.2 Drugs for Osteoarthritis Pain Product Offered
- 11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Johnson & Johnson News
- 11.3 GlaxoSmithKline
- 11.3.1 Company Details
- 11.3.2 Drugs for Osteoarthritis Pain Product Offered
- 11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 GlaxoSmithKline News
- 11.4 Bayer
- 11.4.1 Company Details
- 11.4.2 Drugs for Osteoarthritis Pain Product Offered
- 11.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Bayer News
- 11.5 Eli Lilly
- 11.5.1 Company Details
- 11.5.2 Drugs for Osteoarthritis Pain Product Offered
- 11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Eli Lilly News
- 11.6 Novartis
- 11.6.1 Company Details
- 11.6.2 Drugs for Osteoarthritis Pain Product Offered
- 11.6.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Novartis News
- 11.7 Sanofi
- 11.7.1 Company Details
- 11.7.2 Drugs for Osteoarthritis Pain Product Offered
- 11.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Sanofi News
- 11.8 Horizon Pharma
- 11.8.1 Company Details
- 11.8.2 Drugs for Osteoarthritis Pain Product Offered
- 11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Horizon Pharma News
- 11.9 Abbott
- 11.9.1 Company Details
- 11.9.2 Drugs for Osteoarthritis Pain Product Offered
- 11.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Abbott News
- 11.10 Mylan
- 11.10.1 Company Details
- 11.10.2 Drugs for Osteoarthritis Pain Product Offered
- 11.10.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Mylan News
- 11.11 Daiichi Sankyo
- 11.12 TEVA
- 11.13 Almatica Pharma
- 11.14 Astellas Pharma
- 11.15 Tide Pharmaceutical
- 11.16 Iroko Pharmaceuticals
- 11.17 Hengrui Pharmaceutical
- 11.18 Abiogen Pharma
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Drugs for Osteoarthritis Pain . Industry analysis & Market Report on Drugs for Osteoarthritis Pain is a syndicated market report, published as Global Drugs for Osteoarthritis Pain Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Drugs for Osteoarthritis Pain market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
